Summary
Vergent Bioscience
Founded in 2014
Description
Vergent Bioscience is a clinical stage biotechnology company that is helping surgeons realize the full potential of minimally invasive and robotic assisted surgery by improving the visibility of tumors. Vergents lead compound, VGT 309, is a tumor targ...
Strengths
- Vergent Bioscience has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Revenue growth is more steady than the industry average
- Since Vergent Bioscience was founded, the company has grown faster than the industry average
Annual Revenue
Vergent Bioscience's annual revenue
$873000
Based on Kona Equity data
-
Revenue per employee
$174600
-
Variance of revenue growth
0.24
-
Annual revenue growth since founding
$224666
-
Revenue growth rate from first known quarter to current
-84.0%
Employee Count
5 employees
-
Employee growth rate from first known quarter to current
-83.3%
Executives
John Santini
President & Chief Executive Officer
j**@vergentbio.comEric Yvon
Head of Research & Development
e**@vergentbio.comEric Bensen
Head of Research & Development
e**@vergentbio.comHelen Han
Senior Scientist
h**@vergentbio.comDean Banks
Dean
d**@vergentbio.comPhone Bioscience
President & Chief Executive Officer
p**@vergentbio.comG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G5 Variance of revenue growth is less than the industry average
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Key Information
- Name: Vergent Bioscience
- Category: Pharmaceuticals
- Industry: Store
- SIC: 2834; 283
- NAICS: 32541; 541
See similar companies
-
By City Minneapolis Small Store in Minneapolis Mid-size Store in Minneapolis Pharmaceuticals in Minneapolis Small Pharmaceuticals in Minneapolis Mid-size Pharmaceuticals in Minneapolis
-
By State Minnesota Small companies in Minnesota Pharmaceuticals in Minnesota Small Pharmaceuticals in Minnesota Mid-size Pharmaceuticals in Minnesota Small Store in Minnesota Mid-size Store in Minnesota
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Store Small Store Mid-size Store Pharmaceuticals and Store
-
Firmographic data G Score of 6 Founded in 2014 SIC: 2834 SIC: 283 NAICS: 32541 NAICS: 541 #Pharmaceuticals #Healthcare #Biotechnology #Drug Manufacturing & Research
Frequently Asked Questions
Vergent Bioscience's headquarters are located at 420 North 5th St., Ste 500 222 Minneapolis, Minnesota 55401.
Vergent Bioscience's official website is vergentbio.com
Vergent Bioscience's annual revenue is $873.0 K.
Vergent Bioscience's SIC: 2834; 283
Vergent Bioscience's NAICS: 32541; 541.
Vergent Bioscience has 5 employees
Vergent Bioscience is in the industry of Pharmaceuticals.